Healthcare Disparities in Atopic Dermatitis in Latin America: A Narrative Review
Open Access
- 23 December 2022
- journal article
- review article
- Published by Springer Nature in Dermatology and Therapy
- Vol. 13 (2) , 399-416
Abstract
Introduction Atopic dermatitis (AD) is a chronic, pruritic skin disease caused by a mixture of genetic, immunological, and environmental factors, characterized by periods of inflammation and remission. In Latin America (LA), the prevalence of AD ranges up to 25% in children and 1–3% in adults. The natural history of the disease for most patients is that AD goes into remission in adolescence and adult life. Only 10–30% of patients continue to have symptoms of the disease in adulthood. There are patients (3–4%) who have the onset of AD during adolescence or after adulthood. Those with limited access to healthcare services, such as diagnosis and treatment, have increased difficulties coping with AD. Healthcare disparities are a complex topic that include social, political, racial/ethnic, and geographical factors. Publications about healthcare disparities in AD in LA are scarce. As a result, recognizing and resolving healthcare inequalities is critical to improving the treatment and quality of life (QoL) of individuals with AD. Methods A panel of Latin American experts in dermatology and allergies was provided with a series of relevant questions to address before a multiday conference. During this conference, the entire group discussed and edited each narrative through numerous drafts and rounds of discussion until they reached a consensus. Results This paper examines the barriers to equal access to care and recommends realistic actions to overcome them. Inadequate disease knowledge, cultural and linguistic barriers, stigmatization, maldistribution of resources, absence of local clinical practice guidelines, arduous patient journey, and limited consultation time were identified as causes of health inequality. Conclusions Among the suggested solutions are enhanced education for healthcare professionals, patients, and the general public, a focus on underprivileged communities, telemedicine and telementoring, translators, multidisciplinary teams, and local living clinical practice guidelines.Keywords
Funding Information
- Americas Health Foundation
This publication has 80 references indexed in Scilit:
- Association between environmental factors and current asthma, rhinoconjunctivitis and eczema symptoms in school-aged children from Oropeza Province – Bolivia: a cross-sectional studyEnvironmental Health, 2013
- Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic responseJournal of Allergy and Clinical Immunology, 2011
- Family eczema-history in 2-year olds with eczema; a prospective, population-based study. The PACT-study, NorwayBMC Dermatology, 2011
- Atopic dermatitis and risk factors in poor children from Great Buenos Aires, ArgentinaClinical and Experimental Dermatology, 2009
- New Emollient with Topical Corticosteroid‐Sparing Effect in Treatment of Childhood Atopic Dermatitis: SCORAD and Quality of Life ImprovementPediatric Dermatology, 2008
- Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointmentAllergy, 2008
- Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointmentAllergy, 2008
- Phototherapy in the management of atopic dermatitis: a systematic reviewPhotodermatology, Photoimmunology & Photomedicine, 2007
- Adherence to MedicationNew England Journal of Medicine, 2005
- Predicting children's quality of life in an asthma clinical trial: What do children's reports tell us?The Journal of Pediatrics, 2001